1315 Capital, a leading private investment firm specializing in providing growth capital to commercial-stage healthcare services and related sectors, recently announced a successful capital raise, securing over $500 million through the closure of two funds. The funds, namely 1315 Capital III and 1315 Capital Emerging Growth and Buyout, surpassed their initial targets of $350 million and $150 million, demonstrating robust investor confidence. This achievement aligns with 1315 Capital's strategic focus on fueling the growth of innovative healthcare businesses.
top of page
bottom of page